Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Menarini's Enantyum launched in Spain

June 28, 1996

COX-2 inhibitors from Merck Frosst

June 28, 1996

Toyama's T-614 enters phase I in U.K.

June 21, 1996

Astra reports autoimmune disease treatment agents

June 14, 1996

Generic formulation of Feldene approved

June 14, 1996

Controlled-release naproxen sodium now on U.S. shelves

June 7, 1996

Organon develops potent inhibitor of alpha-glucosidase I

June 7, 1996

Anika Research seeks European marketing approval for Orthovisc

June 7, 1996

Knoll describes antiarthritic and immunomodulator derivatives

June 7, 1996

LJP-394 marketing agreement between La Jolla Pharma and Leo Denmark discontinued

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...